Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer
Clinical trial NCT07180056 · RECRUITING
Trial details
- NCT number
- NCT07180056
- Sponsor
- Wenjin Yin
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-28
- Primary completion
- 2028-02-01
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.